NEWS

Our Latest News

ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics

Global private equity healthcare specialist ARCHIMED announces the acquisition of BioVendor Group, a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research, expanding ARCHIMED’s numerous investments in the diagnostics industry.